tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
X4 Pharmaceuticals (XFOR)
:XFOR
US Market
XFOR
X4 Pharmaceuticals
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Advertisement

X4 Pharmaceuticals (XFOR) Stock News & Sentiment

Compare
1,026 Followers
X4 Pharmaceuticals Advances Phase 3 Study for WHIM Syndrome Treatment
Premium
Company Announcements
X4 Pharmaceuticals Advances Phase 3 Study for WHIM Syndrome Treatment
8d ago
XFOR
X4 Pharmaceuticals Advances Phase 3 Study of Mavorixafor for WHIM Syndrome
Premium
Company Announcements
X4 Pharmaceuticals Advances Phase 3 Study of Mavorixafor for WHIM Syndrome
10d ago
XFOR
X4 Pharmaceuticals Completes Key Study on Mavorixafor’s Drug Interaction Potential
Premium
Company Announcements
X4 Pharmaceuticals Completes Key Study on Mavorixafor’s Drug Interaction Potential
1M ago
XFOR
X4 Pharmaceuticals Completes Key Study on Mavorixafor’s Drug Interaction Potential
Premium
Company Announcements
X4 Pharmaceuticals Completes Key Study on Mavorixafor’s Drug Interaction Potential
1M ago
XFOR
X4 Pharmaceuticals Elects New Director at Annual Meeting
Premium
Company Announcements
X4 Pharmaceuticals Elects New Director at Annual Meeting
2M ago
8K
XFOR
X4 Pharmaceuticals Reports Positive Q1 2025 Results
Premium
Company Announcements
X4 Pharmaceuticals Reports Positive Q1 2025 Results
3M ago
XFOR
X4 Pharmaceuticals’ Earnings Call: Progress Amid Challenges
Premium
Company Announcements
X4 Pharmaceuticals’ Earnings Call: Progress Amid Challenges
3M ago
XFOR
More XFOR News >

XFOR News on the Web

X4 Pharma Unveils Encouraging Phase 2 Data On Mavorixafor At EHA Congress
rttnews
Neutral
X4 Pharmaceuticals Elects New Director at Annual Meeting
TipRanks News
Neutral
Analysts’ Top Healthcare Picks: X4 Pharmaceuticals (XFOR), TriSalus Life Sciences (TLSI)
TipRanks News
Neutral
X4 Pharmaceuticals Inc (XFOR) Q4 2024 Earnings Call Highlights: Strategic Restructuring and ...
GuruFocus News
Neutral
Q4 2024 X4 Pharmaceuticals Inc Earnings Call Transcript
GuruFocus News
Neutral
X4 Pharmaceuticals Inc (XFOR) Q4 2024 Earnings: Revenue Surpasses Estimates at $1. ...
GuruFocus News
Bullish
X4 Pharmaceuticals Inc (XFOR) Q4 2024 Earnings Report Preview: What To Look For
GuruFocus News
Bearish
X4 Pharmaceuticals to Report Fourth-Quarter and Full-Year 2024 Financial Results and Host a Conference Call and Webcast on March 25, 2025
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
XFOR
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average54%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is XFOR’s Media Buzz Sentiment?
Currently, no data Available
What is XFOR’s weekly average amount of articles?
Currently, no data Available
What is XFOR’s News Sentiment?
59% of articles about XFOR were positive this week, compared to its sector average of 54%.
    Healthcare Stocks that are Trending in the News
    IMCRImmunocore Holdings
    CRMDCormedix
    FARNFaron Pharmaceuticals Oy
    OPRXOptimizeRx
    TCMDTactile Systems Technology
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing